Integrated Investment Consultants’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
5,538
-7
-0.1% -$1.74K 0.26% 64
2025
Q4
$1.34M Buy
+5,545
New +$1.42M 0.26% 67
2025
Q1
Sell
-6,025
Closed -$1.38M 334
2024
Q4
$1.38M Buy
+6,025
New +$1.45M 0.28% 66

Other funds holding RMD

Integrated Investment Consultants's RMD Position: Q1 2026 in Review

Integrated Investment Consultants reduced its ResMed (RMD) stake by 0.13% in Q1 2026, selling an estimated $1.74K and leaving 5,538 shares worth $1.24M. The position accounts for 0.26% of the portfolio, ranked #64.

Integrated Investment Consultants first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.38M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Integrated Investment Consultants held 5,538 shares of ResMed worth $1.24M as of Q1 2026.
  • Integrated Investment Consultants sold 7 ResMed shares in Q1 2026, an estimated $1.74K.
  • ResMed made up 0.26% of Integrated Investment Consultants's portfolio in Q1 2026, its #64 holding.
  • Integrated Investment Consultants first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
  • Integrated Investment Consultants's ResMed position peaked at $1.38M in Q4 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Integrated Investment Consultants's 13F filing for Q1 2026, filed 1 Jun 2026.